APPLICATIONS PUBLISHED 4 OCTOBER 2006

Proteins of nutraceutical and biotherapeutic potential
Avestha Gengraine Technologies 1705987*

Immunomodulatory compounds for the treatment of central nervous system disorders
Celgene 1705988*

Substituted arylpyrazoles as parasiticidal agents
Pfizer 1705989*

Modulators of the gluticocorticoid receptor, AP-1, and/or NF-KB activity and use thereof
Bristol-Myers Squibb 1705990*

Intratumoural delivery of dendritic cells
Cedars-Sinai Medical Centre 1705992*

Treatment of ophthalmic conditions
Osio 1706094*

Compsns for localised therapy of the eye, comprising preferably triamcinolone acetinide and hyaluronic acid
Allergan 1706095*

Consumer customised dosage forms
McNeil-PPC 1706096*

Micellar systems useful for delivery of lipohilic or hydrophobic compounds
Supermus Pharmaceuticals 1706098*

A medical product comprising tiotropium in a moisture-proof container
Microdrug 1706099*

Non-aqueous compsns for oral delivery of insoluble bioactive agents
Freidman, Doron 1706100*

Multiparticulate formulations for oral delivery
Vectura 1706101*

Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them
Fournier Laboratories Ireland 1706102*

Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix
Universita Degli Studi di Milano 1706103*

Methods for treating stress and affecting biological immune systems using a cysteamine compound
Omega Bio-Pharma 1706104*

Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
Wisconsin Alumni Research Foundation 1706105*

Use of highly concentrated compsns of selected N-3 fatty acids for the treatment of central nervous system disturbances
Bruzzese, Tiberio 1706106*

Synergistic neuroprotective combinations of flavanols, flavanones, flavones, flavonols, proanthrocyanidins and anthocyanidins
Unilever 1706107*

Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
Md Bioalpha 1706108*

Isoflavone therapy for treating urinary incontinence
Archer-Daniels-Midland 1706109*

Therapeutic use of quinonoid derivatives of cannabinoids
Yissum Research Development Company of the Hebrew University of Jerusalem 1706110*

Compounds, compsns and methods
SmithKline Beecham 1706111*

Methods of treating an inflammatory-related disease
Natrogen Therapeutics 1706112*

A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
USV 1706113*

Chemical inhibitors of soluble adenylyl cyclase (SAC)
Cornell Research Foundation 1706114*

Controlled release pharmaceutical compsn comprising an acid-insoluble and a bioadhesive polymer
Panacea Biotec 1706115*

Pharmaceutical compsns
Schering 1706116*

Method for treating erectile dysfunction
Astellas Pharma 1706117*

New pharmaceutical compsns based on a scopine ester and nicotinamide derivatives
Boehringer Ingelheim 1706118*

Novel pharmaceutical combinations containing scopine or tropic acid esters and EGFR-kinase inhibitors
Boehringer Ingelheim 1706119*

New derivatives of 6-4,4-1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl pyradizin-3-one
AstraZeneca 1706120*

Neutral endopeptidase (NEP) and human soluble endopeptidase (HSEP) inhibitors for prophylaxis and treatment of neurodegenerative disorders
Solvay Pharmaceuticals 1706121*

Anti-viral pharmaceutical compsns
SD Pharmaceuticals 1706122*

Compsns derived from portulaca oleracea L and methods of using same for modulating blood glucose levels
D-Herb 1706123*

A compsns comprising the extract of Cucurbitaceae family plant or the purified extract isolated thereform having anti-adipogenic and anti-obesity activity
Helixir 1706124*

Methods for treating prostatic intraepithelial neoplasia with herbal compsns
New Chapter 1706125*

Method and compsns for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and reducing populations of bacteria
Biofilms Strategies 1706126*

Penetration enhancing agent and method of its production from the hemp seeds
Parenteral 1706127*

Pharmaceutical compsns and methods for insulin treatment
Bentley Pharmaceuticals 1706128*

Drug therapy for celiac sprue
The Board of Trustees of the Leland Stanford Junior University 1706129*

Matrix-array nanobiosensor
Nano-Proprietary 1706130*

Helical synthetic peptides that stimulate cellular cholesterol efflux
The Regents of the University of California 1706131*

A compsns for cartilage therapeutics and using method thereof
Sewon Cellontech 1706132*

Methods of protecting against radiation using flegellin
Cleveland Clinic Foundation 1706133*

Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
DeveloGen Aktiengesellschaft 1706134*

A treatment for necrotising enterocolitis
University Technologies International 1706135*

Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent
Regenerx Biopharmaceuticals 1706136*

M-CSF muteins and uses thereof
Chiron 1706137*

Methods for treating inflammation using thyroid stimulating hormone
ZymoGenetics 1706138*

Lysyl oxidase-like 1 (LOXL1) and elastogenesis
Massachusetts Eye & Ear Infirmary 1706139*

Methods for tailoring the immune response to an antigen or immunogen
Biomedical Research Models; Oral Vaccine Technologies 1706140*

Methods of using botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)
Botulinum Toxin Research Associates 1706141*

Streptococcus phocae vaccine
Intervet International 1706142*

CD40 antibody formulations and methods
Pfizer 1706143*

Medicament comprising inhibitors of long pentraxin PTX3
Defiante Farmaceutica 1706144*

Autoantibodies used as carrier agents for pharmaceutical compounds using in tumour imaging and cancer treatment
Smith, Henry J 1706145*

Nutrient compsns and methods for enhanced effectiveness of the immune system
Integrative Health Consulting 1706146*

Combination therapy with 5-HT SB 1A/SB and 5-HT SB 1B/SB receptor antagonists
Recordati Ireland 1706147*

Lipid-based dispersions useful for drug delivery
Gilead Sciences 1706148*

Liposome compsn for delivery of therapeutic agents
Alza 1706149*

Stable growth hormone liquid delivery formulation
Pharmacia 1706150*

Method of protecting sensitive molecules for a photopolymerising environment
Massachusetts Institute of Technology 1706151*

Particle-induced ghrelin immune response
Cytos Biotechnology 1706152*

Minimal lentiviral vector system
Children's Hospital of Los Angeles Research Institute 1706153*

Improved gastrin releasing peptide compounds
Bracco Imaging 1706154*

Polymeric micellar complexes and drug delivery vehicles thereof
SmithKline Beecham 1706155*

Method for providing a polymeric implant with a crystalline calcium phosphate coating
Stichting Katholieke Universiteit 1706156*

Method for the production of intervertebral disk tissue from degenerate intervertebral disk tissue
Co.Don 1706157*

Process for crystallisation of ramipril and preparation of a hydrated form thereof
Lupin 1706378*

Diarylmethylidene piperidine derivatives, preparations thereof, and uses thereof
AstraZeneca 1706379*

Diarylemthlidine piperidine derivatives, preparations thereof and uses thereof
AstraZeneca 1706380*

Process for the manufacture of 2,3-dichloropyridine
EI du Pont de Nemours 1706381*

Method for stabilising 4-halogenpyridines with secondary and/or tertiary amines
Sanofi-Aventis Deutschland 1706382*

Amine salt of carbostyril derivative
Otsuka Pharmaceutical 1706383*

Therapeutic agents I
AstraZeneca 1706384*

Pyrazole derivatives as protein kinase modulators
Astex Therapeutics; Cancer Research Technology; Institute of Cancer Research, Royal Cancer Hospital 1706385*

Bicyclic derivatives as PPAR modulators
Eli Lilly 1706386*

Therapeutic agents II
AstraZeneca 1706388*

3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses
Boehringer Ingelheim International 1706389*

Isoxazole derivatives and their use as cyclooxygenase inhibitors
Universita degli studi di Bari; Universita Degli Studi di Chieti 1706390*

Modulators of glucocorticoid receptor, AP-1, and/or NF-&(K)-beta activity and use thereof
Bristol-Myers Squibb 1706391*

Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
AstraZeneca 1706393*

Preparation of excitalopram
Dr Reddy's Laboratories 1706394*

Thiophene and furan compounds
Eli Lilly 1706395*

N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors XA, IXA and thrombin induced by factor VIIA
F Hoffmann-La Roche 1706396*

Novel amorphous form of omeprazole salts
Ranbaxy Laboratories 1706397*

Amino-benzazoles as P2Y1 receptor inhibitors
Bristol-Myers Squibb 1706398*

Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
Elan Pharmaceuticals 1706399*

Phenyl-4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl-amine derivatives as IGF-1R inhibitors
Novartis 1706400*

Preparation of olmesartan medoxomil
Teva Pharmaceutical Industries 1706401*

Cathepsin cysteine protease inhibitors
Merck Frosst Canada 1706402*

Imidazo[4,5-C]pyridine compounds and methods of antiviral treatment
K U Leuven Research & Development; Puerstinger, Gerhard; Gilead Sciences 1706403*

Tetrahydrocarboline compounds as anticancer agents
Chiron Corp 1706404*

4'-substituted carbovir- and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity
Gilead Sciences 1706405*

Process for the preparation of valacyclovir hydrochloride
Teva Pharmaceuticals 1706406*

Novel crystalline form of temozolomide
Chemagis 1706407*

Processes for the preparation of pyrazolo[1,5-A]-1,3,5-triazines and intermediates thereof
Bristol-Myers Squibb 1706408*

Compounds useful in therapy
Pfizer 1706409*

Pyrrolopyrimidine and pyrrolotriazine derivatives as CRF receptor antagonists
Taisho Pharmaceutical 1706410*

Method for preparing phthalocyanines
BASF 1706411*

Novel pyridine derivatives, a process for their preparation and a pharmaceutical compsn containing the same
SK Chemicals 1706412*

Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases
Bayer Healthcare 1706413*

Process for fluorocytidine derivatives
F Hoffmann-La Roche 1706414*

Lipid-derivatised bisphosphoric acid
MCS Micro Carrier Systems 1706415*

Chimera botulinum toxin type E
Allergan 1706416*

A novel protein capable of inhibiting anthrax toxin activity
Council of Scientific and Industrial Research 1706417*

Live genetically attenuated malaria vaccine
Seattle Biomedical Research Institute 1706418*

Modified fusion peptides derived from a P53 domain against malignant and/or transformed mammalian cells
The Research Foundation of the State University of New York 1706419*

Site-specific coupling of polypeptides
Pharmexa 1706420*

Methods of modulating cytokine activity; related reagents
Schering 1706421*

Nucleic acid encoding a guinea pig prostaglandin receptor protein and methods of use thereof
Aventis Pharmaceuticals 1706422*

Therapeutic and diagnostic anti-HSP 70 antibodies
multimmune 1706423*

FC region variants
Applied Molecular Evolution 1706424*

Human anti-pseudomonas-aeruginosa antibodies derived from transgenic Xenomouse
Schreiber, John 1706425*

Nogoa antibodies for the treatment of Alzheimer's disease
Glaxo Group 1706426*